Golden
GEA Enzymes

GEA Enzymes

GEA Enzymes is a biotechnology company, founded in 2015, based in San Francisco that uses artificial intelligence to design protein and enzyme products for both food industry and pharmaceuticals.

All edits

Edits on 30 May 2019
Golden AI
Golden AI edited on 30 May 2019 10:22 pm
Edits made to:
Infobox (+1 properties)
Edits on 29 May 2019
Golden AI
Golden AI edited on 29 May 2019 9:23 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 23 May 2019
Golden AI
Golden AI edited on 23 May 2019 11:52 am
Edits made to:
Infobox (+1 properties)

Infobox

Location
Edits on 7 Mar 2019
Golden AI
Golden AI edited on 7 Mar 2019 10:36 pm
Edits made to:
Infobox (+2 properties)

Infobox

Edits on 30 Jan 2019
Melanie Manipula
Melanie Manipula edited on 30 Jan 2019 5:34 am
Edits made to:
Infobox (+1 properties)
Article (+8/-7 characters)
Categories (+2 topics)

Article

The GEA Enzymes team comes from Santiago, Chile, where they designed MADI (Molecular Affinity Device Interface) , a machine learning platform to design and create synthetic proteins . MADI is under trade secret. GEA Enzymes further developed their technology in San Francisco with the IndiBioIndieBio accelerator program.

Infobox

Categories

Jed Christiansen"Approved suggestion from source: https://twitter.com/geaenzymes"
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:32 am
Edits made to:
Topic thumbnail

GEA Enzymes

GEA Enzymes is a biotechnology company, founded in 2015, based in San Francisco that uses artificial intelligence to design protein and enzyme products for both food industry and pharmaceuticals.

Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:31 am
Edits made to:
Article (+8/-8 characters)

Article

GEA Enzymes have received government and public funding from Chile and private investments from Chile and the US . They have received $500K in total funding from Start-Up Chile, CORFO, Angel Investors, SOSV with partner Arvind Gupta and IndieBioIndieBio.

Jed Christiansen"Approved suggestion from source: http://geaenzymes.com/"
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:31 am
Edits made to:
Infobox (+1 properties)
Jed Christiansen"Approved suggestion from source: http://geaenzymes.com/"
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:31 am
Edits made to:
Infobox (+1 properties)
Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:31 am
Edits made to:
Article (+11/-11 characters)

Article

MADI uses Deep Learning, a type of artificial intelligence that uses artificial neural networks to scan data sets and look for patterns. Amino acidsAmino acids are the building blocks of proteins. MADI can correlate certain amino acid sequences and other factors with how the protein will fold and be shaped and is used to create designer enzymes, proteins and peptides. An enzyme is a type of protein that binds to other molecules and speeds up chemical reactions that change the molecular structure .

Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:31 am
Edits made to:
Article (+13/-13 characters)

Article

The GEA Enzymes team comes from Santiago, Chile, where they designed MADI (Molecular Affinity Device Interface) , a machine learning platform to design and create synthetic proteins . MADI is under trade secret. GEA Enzymes further developed their technology in San FranciscoSan Francisco with the IndiBio accelerator program.

Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:31 am
Edits made to:
Article (+12/-12 characters)

Article

GEA Enzymes have received government and public funding from Chile and private investments from Chile and the US . They have received $500K in total funding from Start-Up Chile, CORFO, Angel Investors, SOSV with partner Arvind GuptaArvind Gupta and IndieBio.

Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:31 am
Edits made to:
Article (+4/-4 characters)

Article

GEA Enzymes have received government and public funding from Chile and private investments from Chile and the US . They have received $500K in total funding from Start-Up Chile, CORFO, Angel Investors, SOSVSOSV with partner Arvind Gupta and IndieBio.

Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:31 am
Edits made to:
Article (+8/-8 characters)

Article

The GEA Enzymes team comes from SantiagoSantiago, Chile, where they designed MADI (Molecular Affinity Device Interface) , a machine learning platform to design and create synthetic proteins . MADI is under trade secret. GEA Enzymes further developed their technology in San Francisco with the IndiBio accelerator program.

Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 30 Jan 2019 1:31 am
Edits made to:
Article (+13/-13 characters)

Article

MADI uses Deep LearningDeep Learning, a type of artificial intelligence that uses artificial neural networks to scan data sets and look for patterns. Amino acids are the building blocks of proteins. MADI can correlate certain amino acid sequences and other factors with how the protein will fold and be shaped and is used to create designer enzymes, proteins and peptides. An enzyme is a type of protein that binds to other molecules and speeds up chemical reactions that change the molecular structure .

Edits on 29 Jan 2019
Golden AI
Golden AI edited on 29 Jan 2019 6:49 pm
Edits made to:
Infobox (+2 properties)

Infobox

Incubator Batch
Founded
2015
Edits on 28 Jan 2019
Jed Christiansen
Jed Christiansen edited on 28 Jan 2019 7:37 pm
Edits made to:
Infobox (-1 properties)
Golden AI
Golden AI edited on 28 Jan 2019 2:22 pm
Edits made to:
Infobox (+10 properties)
Edits on 9 Jul 2018
Michael Mangus"move website link to infobox"
Michael Mangus edited on 9 Jul 2018 7:40 pm
Edits made to:
Description (+11/-11 characters)
Topic thumbnail

GEA Enzymes

GEA EnzymesGEA Enzymes is a biotechnology company, founded in 2015, based in San Francisco that uses artificial intelligence to design protein and enzyme products for both food industry and pharmaceuticals.

Infobox

Edits on 1 Jul 2018
Meredith Hanel
Meredith Hanel edited on 1 Jul 2018 2:55 pm
Edits made to:
Description (+196 characters)
Article (+2162 characters)
People (+7 rows) (+14 cells) (+234 characters)
Further reading (+2 rows) (+6 cells) (+278 characters)
Documentaries, videos and podcasts (+1 rows) (+3 cells) (+86 characters)
Topic thumbnail

GEA Enzymes

GEA Enzymes is a biotechnology company, founded in 2015, based in San Francisco that uses artificial intelligence to design protein and enzyme products for both food industry and pharmaceuticals.

Article

The GEA Enzymes team comes from Santiago, Chile, where they designed MADI (Molecular Affinity Device Interface) , a machine learning platform to design and create synthetic proteins . MADI is under trade secret. GEA Enzymes further developed their technology in San Francisco with the IndiBio accelerator program.

MADI uses Deep Learning, a type of artificial intelligence that uses artificial neural networks to scan data sets and look for patterns. Amino acids are the building blocks of proteins. MADI can correlate certain amino acid sequences and other factors with how the protein will fold and be shaped and is used to create designer enzymes, proteins and peptides. An enzyme is a type of protein that binds to other molecules and speeds up chemical reactions that change the molecular structure .



Products



Food Industry



GEA Enzymes food applications are in the chocolate, vegetable oil and dairy industries. For cooking oils, GEA is developing enzymes that can improve the fatty acid composition to improve quality when fatty acid ratios are inconsistent . This can benefit vegetable oils because the quality of the raw plant ingredient used to make the oils can vary unpredictably due to climate and soil conditions. Their designer enzymes can change saturated fats to unsaturated fats. Since saturated fats are associated with obesity and heart disease this can make some foods healthier . By changing saturated fats to unsaturated fats GEA Enzymes created dark chocolate that melts at room temperature . Their product DairySain is a group of enzymes that reduce saturated fats quickly and easily from dairy products .



Pharmaceuticals



While proteins are long chains of amino acids, peptides are short chains of amino acids that have potential as antimicrobial agents or as drugs. Peptides can bind to and target specific molecules in the body. GEA Enzymes is designing peptides to bind glucose.



Funding



GEA Enzymes have received government and public funding from Chile and private investments from Chile and the US . They have received $500K in total funding from Start-Up Chile, CORFO, Angel Investors, SOSV with partner Arvind Gupta and IndieBio.

People

Name
Role
Related Golden topics

Andrés Castillo

Senior protein engineer



Fabian Gonzalez

Protein design and project manager



Francia Navarrete

Founder, COO



Juan Carlos Duarte

Founder, CTO



Leonardo Álvarez

Founder, CEO



Mitzi Sandoval

Lab manager



Richard Rubin

VP Sales and Marketing



Further reading

Author
Title
Link
Type

Liederbach, K.

An Interview with Francia Navarrete Utreras of GEA Enzymes



Documentaries, videos and podcasts

Title
Date
Link

Spring Summit 2018: GEA Enzymes

May 10, 2018